MarginsXMarginsX
Home › Markets › Health Care › NAGE

Niagen Bioscience Inc. (NAGE)

NAGE trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.01
-2.66% on the day
Market cap
$159.2M
Micro cap
Revenue · 2025
$129.4M
+29.9% on 2024
Net income · 2025
$17.4M
13.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1386570/000138657026000013/0001386570-26-000013-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNAGE on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001386570
SEC industry codeMedicinal Chemicals & Botanical Products
Incorporated inDE

Financials · 2025

LineValue
Revenue$129.4M
Net income$17.4M
Operating income$16.3M
Net margin13.4%
Operating margin12.6%
Revenue growth+29.9%
Cash$64.8M
Total assets$106.4M
P/E (computed)9.2×
P/S (computed)1.2×

Warning signs

Cash runway
Cash-flow positive
$69.5M cash at September 30, 2026
Share count, 1 year
-0.8%
2025-11-03 to 2026-10-30 · +5.4% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
$46K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$69.5M cash; operating cash flow $1.2M a quarter.Report 2026-09-30
Shares outstanding79,196,903 (2026-10-30); 79,806,139 a year earlier; 75,124,418 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-07-10
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCrowe LLP, Costa Mesa, California, United States; changed auditors 1 time in 24 months8-K 4.01 2024-12-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $46K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$27.2M-$1.2M$2.6M$69.5MNo debt tags$122.3M10-Q 2026-11-04
Q2 2026
2026-06-30
$29.8M$963K$2.8M$66.7MNo debt tags$129.1M10-Q 2026-08-04
Q1 2026
2026-03-31
$31.5M$6.3M-$1.2M$66.5MNo debt tags$130.4M10-Q 2026-05-06
Q4 2025
2025-12-31
$33.8M$4.1M$679K$64.8MNo debt tags$129.4M10-K 2026-03-04
Q3 2025
2025-09-30
$34.0M$4.6M$3.7M$64.1MNo debt tags$124.7M10-Q 2026-11-04
Q2 2025
2025-06-30
$31.1M$3.6M$1.3M$60.3MNo debt tags$116.3M10-Q 2026-08-04
Q1 2025
2025-03-31
$30.5M$5.1M$7.9M$55.5MNo debt tags$107.9M10-Q 2026-05-06
Q4 2024
2024-12-31
$29.1M$7.2M$8.6M$44.5MNo debt tags$99.6M10-K 2026-03-04

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52026-07-10
Latest annual report10-K2026-03-04
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 981 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week0.0%
1 month-19.8%
3 months-32.1%
Year to date-67.5%
1 year-70.4%
From 52-week high-70.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
MDWDMediWound Ltd.$13.55+5.04%$195.0M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
ISPRIspire Technology Inc.$1.52-10.06%$87.8M
ACBAurora Cannabis Inc. Common Shares$4.61-6.68%$303.1M
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier